Clinical Trials · NCT00747500
Non Interventional Post Marketing Programme in Acromegaly
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Ipsen
- Enrollment
- 42
- Start date
- Jul 2008
- Locations
- 7 sites, United Kingdom
- Primary endpoint
- safety and local tolerability of Somatuline Autogel when administered by patients or their partners or from a healthcare professional